21 CFR Part 11 Explained: Compliance Requirements & Common Mistakes

In life sciences, accuracy and traceability are regulatory imperatives. Organizations working in pharmaceuticals, biotechnology, and medical devices must adhere to strict standards that govern how electronic records and signatures are handled. One of the most critical of these regulations is 21 CFR Part 11. 

This blog explains the regulation in clear terms, outlines the key compliance requirements, highlights common mistakes, and provides guidance on how to implement the right systems to meet compliance expectations. 

What Is 21 CFR Part 11? 

21 CFR Part 11 is a section of the Code of Federal Regulations issued by the U.S. Food and Drug Administration (FDA). It outlines the criteria of acceptance under which electronic records and electronic signatures are considered equivalent to their paper counterparts. 

Its purpose is to ensure that electronic systems used in regulated environments maintain data integrity, confidentiality, accountability, and traceability throughout the record lifecycle. 

This regulation affects any company subject to FDA oversight that uses electronic systems for: 

• Product development and testing 

• Manufacturing or lab operations 

• Quality control and assurance 

• Documentation and recordkeeping 

Whether you’re submitting documentation to the FDA, storing SOPs, or approving validation protocols, Part 11 compliance is mandatory when those processes involve digital systems. 

Why 21 CFR Part 11 Matters 

Electronic systems are now standard in life sciences, but without appropriate controls, they can introduce significant compliance risk. Falsified data, uncontrolled changes, or improperly authenticated signatures can result in regulatory action, rejected submissions, or even risks to patient safety. 

Noncompliance can lead to: 

• FDA warning letters or 483 observations 

• Product recalls 

• Delays in approvals 

• Fines and reputational damage 

21 CFR Part 11 ensures that digital processes are as trustworthy and transparent as traditional paper-based methods—if not more so. 

Key Compliance Requirements 

To achieve compliance, organizations must implement technical and procedural controls across all relevant systems. Below are the primary requirements outlined in Part 11, along with what each one means in practice. 

1. System Validation

All systems used to create, modify, maintain, or transmit electronic records must be validated. This means proving—through documented testing—that the system performs as intended, consistently and reliably. 

Best practices include: 

• Creating a validation plan with defined scope and risk assessment 

• Executing installation (IQ), operational (OQ), and performance qualification (PQ) 

• Maintaining validation documentation for auditors 

2. Audit Trails

Systems must generate a secure, time-stamped audit trail that logs all user activity related to record creation, modification, and deletion. This audit trail must not be alterable and must be available for review upon request. 

Key components: 

• Who made the change 

• What was changed 

• When the change occurred 

• The reason or justification (if applicable) 

3. Access Controls

Only authorized individuals should have access to regulated systems. This includes the use of unique usernames and passwords, role-based permissions, and the ability to revoke access when necessary. 

4. Electronic Signatures

Electronic signatures must be: 

• Unique to the individual 

• Verified through multiple factors (such as password + username) 

• Linked to specific records to prevent repudiation 

The system must also capture metadata about each signature, including the signer’s name, the date and time, and the purpose of the signature (e.g., review, approval, authorship). 

5. Record Retention and Retrieval

Regulated records must be stored securely for the duration of their retention period and be easily retrievable in a human-readable format. Systems must ensure that data is not lost, corrupted, or inappropriately altered. 

6. Training and Procedural Documentation

Organizations must ensure that all users are adequately trained and that standard operating procedures (SOPs) are in place for using electronic systems in a compliant manner. Documentation should cover everything from system access to change control processes. 

Common Compliance Mistakes to Avoid 

Even companies that are aware of 21 CFR Part 11 often fall into avoidable traps. Here are some of the most frequent mistakes —and why they matter. 

Mistake 1: Relying on Vendor Claims Alone 

Software vendors may claim their systems are “21 CFR Part 11 compliant,” but compliance isn’t just about the software itself; how the software is configured, validated, and used also comes into play. You’re responsible for validating the system in your own environment and ensuring the necessary procedural controls are in place. 

Mistake 2: Missing or Incomplete Audit Trails 

Some systems lack native audit trail capabilities or require manual activation. If you can’t automatically track key user actions (like changes to data or signatures), you’re likely out of compliance. 

Mistake 3: Weak User Authentication 

Shared logins, weak passwords, or lack of multi-factor authentication all increase your risk. If the system can’t tie specific actions to individual users, you’ll lack the accountability required by the FDA. 

Mistake 4: Poor Validation Documentation 

Validation isn’t just a one-time task. Re-validation might be needed after significant system updates. If your records are incomplete, unorganized, or out of date, inspectors may consider your validation inadequate —even if the system works as intended. 

Mistake 5: Overlooking Hybrid Workflows 

Many organizations still use a mix of digital and paper records but assume that compliance only applies to the electronic side. The FDA expects end-to-end traceability, regardless of format. Hybrid workflows must be documented and controlled just as rigorously. 

How PSC Software Helps You Stay Compliant 

PSC Software’s Adaptive Compliance Engine (ACE®) was built specifically to support compliance with 21 CFR Part 11 and other global regulatory requirements. It includes: 

• Validation-ready workflows for rapid deployment 

• Automatic, tamper-proof audit trails 

• Secure electronic signature capture 

• Role-based access control with robust authentication 

• Integrated document management and training tracking 

Our system is configurable to your business needs while maintaining compliance at its core, helping your team stay inspection-ready without sacrificing speed or flexibility. 

Final Thoughts 

Compliance with 21 CFR Part 11 is not optional for FDA-regulated companies. As life sciences organizations continue to digitize their operations, understanding and implementing these requirements is essential to avoid risk, ensure product quality, and build trust with regulators. 

By investing in the right systems and processes, you can not only meet FDA expectations—but operate more efficiently, securely, and confidently. 

Learn How PSC Software Supports 21 CFR Part 11 Compliance 

Looking for a solution that’s built with compliance in mind from day one? Request a demo to see how PSC Software can help your team manage electronic records and signatures securely, efficiently, and in full alignment with regulatory expectations.